Danaher Corporation $DHR Shares Acquired by Temasek Holdings Private Ltd

Temasek Holdings Private Ltd increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 53.6% in the third quarter, Holdings Channel reports. The firm owned 168,806 shares of the conglomerate’s stock after acquiring an additional 58,906 shares during the period. Temasek Holdings Private Ltd’s holdings in Danaher were worth $33,467,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. WFA of San Diego LLC acquired a new position in shares of Danaher during the second quarter worth about $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Danaher in the third quarter valued at about $27,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the second quarter valued at about $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher during the 3rd quarter valued at about $28,000. Finally, Tripletail Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter valued at about $31,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of analyst reports. KeyCorp restated an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. JPMorgan Chase & Co. lifted their price objective on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. Morgan Stanley initiated coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 target price on the stock. Argus set a $265.00 target price on shares of Danaher in a research note on Wednesday, January 14th. Finally, Jefferies Financial Group raised their price target on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a report on Wednesday, January 28th. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $253.55.

Danaher Price Performance

Shares of NYSE DHR opened at $187.34 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The business has a 50 day moving average price of $218.79 and a two-hundred day moving average price of $215.34. The firm has a market cap of $132.47 billion, a PE ratio of 37.17, a price-to-earnings-growth ratio of 2.52 and a beta of 0.93.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the company posted $2.14 EPS. Sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.40 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s dividend payout ratio is currently 25.40%.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.